Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - a scoping review
<p><strong>Background:</strong> The limited supply of universal plasma has resulted in transfusion of ABO incompatible plasma to patients. As the need to implement whole blood transfusion in pre-hospitals setting rises, the lowest cut-off for anti-A/anti-B that does not cause haemo...
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
Elsevier
2022
|